Preparing a seasonal flu vaccine with the G186V mutation may prevent a vexing problem that commonly occurs during the vaccine manufacturing process.

The International AIDS Vaccine Initiative (IAVI) announced the start of a Phase I clinical trial to test a novel HIV vaccine candidate, an advance in vaccine design enabled by Scripps Research discoveries.

In a breakthrough with applicability across many flu strains, researchers find a potential small molecule that mimics antibodies to treat disease.

Investigational therapeutic candidate made with four antibodies tethered together shows promise against influenza A and B.

“It’s as if they link arms together to form a stronger complex…”

“We have a great team here at Scripps Research for rational design of vaccines.”